NOT:ETR
Novartis AG
136,84 €
arrow_upward
+0,26%(+0,36) 1D
21 okt, 17:30:00 GMT+2 · EUR
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
insights_autoNOT üçün ən vacib statistik məlumatlar yaradılır...
Açın
136,56 €
Yüksək
137,28 €
Aşağı
136,02 €
Bazar kapitalizasiyası
311,89 mlrd
Ortalama həcm
7,35K
Həcm
2,79K
52 həftəlik ən yüksək
144,12 €
52 həftəlik ən aşağı
104,52 €
İşçilərin sayı
75K
Açın
136,56 €
Yüksək
137,28 €
Aşağı
136,02 €
Bazar kapitalizasiyası
311,89 mlrd
Ortalama həcm
7,35K
Həcm
2,79K
52 həftəlik ən yüksək
144,12 €
52 həftəlik ən aşağı
104,52 €
İşçilərin sayı
75K
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
Yahoo Finance
·
48 dəqiqə öncə
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
AD HOC NEWS
·
1 saat öncə
Novartis stock: UBS keeps Hold rating and CHF 116.00 target for Novartis stock
AD HOC NEWS
·
9 saat öncə
Novartis stock has investor call on October 23 ahead of Xetra open
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Novartis AG haqqında
Baş İcraçı DirektorVasant Narasimhan
İşçilər75,3K
Təsis Tarixi7 mar 1996
Baş OfisBazel, Basel City, İsveçrə
SektorPharmaceutical industry
Veb-saytnovartis.com